Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000834

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2022 · Mar 31, 2022 −$55.07K
Stockholders Equity Q2 2022 · Mar 31, 2022 −$440.1K
Stockholders Equity Q2 2022 · Dec 31, 2021 −$385.54K
Stockholders Equity Q2 2022 · Sep 30, 2021 −$326.19K
Total Liabilities Q2 2022 · Mar 31, 2022 $620.31K
Total Liabilities Q2 2022 · Sep 30, 2021 $587.34K
Total Assets Q2 2022 · Mar 31, 2022 $180.21K
Total Assets Q2 2022 · Sep 30, 2021 $261.15K
Net Income Q2 2022 · Mar 31, 2022 −$54.56K
Net Income Q2 2022 · Mar 31, 2022 −$113.92K
Net Income Q2 2022 · Dec 31, 2021 −$59.36K
Operating Income Q2 2022 · Mar 31, 2022 −$46.56K
Operating Income Q2 2022 · Mar 31, 2022 −$98.62K
Operating Income Q2 2022 · Mar 31, 2021 −$43.24K